Earnings call briefThird-quarter 2026
Thermo Fisher Scientific raises 2026 free cash flow outlook to $7 billion to $7.5 billion
Thermo Fisher Scientific assumes $4 billion of 2026 share buybacks, with $3 billion completed in January and $1 billion in the second quarter.
GetSignal
Thermo Fisher Scientific said on its third-quarter call on October 21, 2026, that it expects net capital expenditures of $1.9 billion to $2 billion in 2026. At the midpoint, the company said it is increasing full-year adjusted EPS guidance by $0.15, including $0.05 from the net impact of tariff refund recovery after deploying about $40 million of additional reinvestment in the fourth quarter.
Quotes from the call
“We expect between $1.9 billion and $2 billion of net capital expenditures in 2026, and we are raising our expected free cash flow range to be between $7 billion and $7.5 billion for the year.”
“...we are assuming $4 billion of share buybacks, with $3 billion completed in January and $1 billion completed in the second quarter.”
Key facts from the call
- Expected 2026 net capital expenditures
- $1.9 billion to $2 billion
- 2026 free cash flow outlook
- $7 billion to $7.5 billion
- 2026 share buybacks assumed
- $4 billion
Source: Thermo Fisher Scientific's third-quarter 2026 earnings call, October 21, 2026.
Written by GetSignal with AI from the company's earnings call. How we make news
Not investment advice.
More earnings call briefs
The newest- DPC Holdings raises 2026 guidance and sets 2027 outlook
DPC · DPC Holdings · Q3 2026 call · Nov 12, 2026
- Enhanced Group expects its sports business to break even or better in 2027
ENHA · Enhanced Group Inc. Class A · Q3 2026 call · Nov 12, 2026
- Cerebras Systems says hardware mix will be closer to 50% in fourth quarter
CBRS · Cerebras Systems · Q3 2026 call · Nov 12, 2026
- Nu Holdings now expects a 2026 efficiency ratio of 19% to 19.5%
NU · Nu Holdings · Q3 2026 call · Nov 12, 2026
